Gilead Sciences (GILD) Tops Q4 EPS by 9c, Offers FY17 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. CRWV
10. IBM

Go back to Gilead Sciences (GILD) Tops Q4 EPS by 9c, Offers FY17 Guidance

Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results

February 7, 2017 4:01 PM EST

- Fourth Quarter Product Sales of $7.2 billion -

- Full Year 2016 Product Sales of $30.0 billion -

- Full Year 2016 Diluted EPS of $9.94 per share -

- Full Year 2016 Non-GAAP Diluted EPS of $11.57 per share -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2016. Total revenues for the fourth quarter of 2016 were $7.3 billion, compared to $8.5 billion... More